| Biomarker ID | 1153 |
| PMID | 23824564 |
| Year | 2013 |
| Biomarker | 5,6-dihydrouracil +choline phosphate+ glycerol + methylpalmitate |
| Biomarker Basis | Concentration Based |
| Biomolecule | Metabolites |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Differentially Expressed |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | Organ Confined Vs Non Orgnan Confined |
| Type of Biomarker | Prognostic |
| Cohort | 260 patients with Prostate cancer such that 67 had organ Confined Disease and 193 had Non Organ Confined Disease |
| Senstivity | NA |
| Specificity | NA |
| AUC | 0.62 |
| Accuracy | NA |
| Level Of Significance | p<0.05 |
| Method Used | gas chromatography-mass spectrometry (GC–MS) |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Validated on independent patient dataset |
| Technical Name | NA |